Water Homeostasis in Propofol Based Total Intravenous Anesthesia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-19

Study Completion Date

2021-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Previous study reported that propofol binded to glutamate receptors in the hypothalamus and inhibits AVP release mediated by endogenous γ-aminobutyric acid, as well as directly inhibits the regulated calcium currents leading to normal neuronal depolarization and AVP release. However, there is no clinical data demonstrating the mechanism of propofol can induce transient DI by inhibiting the release of AVP from the hypothalamus when applied to humans. Remifentanil, binding to the μ-receptor or partly κ-receptor, have been used in total intravenous anesthesia combined with propofol, also reported inhibiting AVP relaese in both the hypothalamus (κ receptor mediator mechanism) and posterior pituitary (μ receptor mediator mechanism). However, the effects of anesthetics on water homeostasis during surgery have been not well established. Therefore, we aim to investigate the changes of intraoperative water homeostasis, and related hormones and osmolality in patients with propofol based total intravenous anesthesia due to neuromonitoring for spine surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Post-Operative Water Load Following Transsphenoidal Pituitary Surgery

NCT02727686

Hyponatremia Pituitary Adenoma

COMPLETED NA

The Association Between Intraoperative Hypotension and Perioperative Stroke

NCT04117867

Perioperative Complication Intraoperative Hypotension

UNKNOWN

Comparison of Stroke Volume Variation-guided Normovolemic and Restrictive Fluid Management During Craniotomy: a Randomized Controlled Trial

NCT02113358

Supratentorial Neoplasms Brain Tumor, Primary Craniotomy

UNKNOWN NA

Norepinephrine Prevent Post-induction Hypotension in High-risk Patients

NCT06028256

Anesthesia Blood Pressure Norepinephrine

UNKNOWN PHASE4

Hypokalemia and Intravenous Patient Controlled Analgesia

NCT01269099

General Anesthesia Laparoscopic Cholecystectomy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

"All patients will get the total intravenous anesthesia with propofol-remifentanil via an effective site-controlled infusion (TCI). For this, TCI continuous infusion pump will be used with Schnider pharmacokinetic model for propofol and Minto pharmacokinetic model for remifentanil. Propofol and remifentanil will be initiated with target effective site concentrations of 3 μg.ml-1 and 3 ng.ml-1, respectively, and controll these concentrations considering patient's consciousness loss and vital signs. And then 0.6 mg kg-1 rocuronium for muscle relaxation will be administered for intubation. Anesthesia will be maintained with BIS level 40-60 and vital signs will not be more than 20% of the baseline or less. In order to prevent the sudden movement of the patient during surgery, rocuronium will be infused continuously about 50% of TOF until the end of intraoperative neuromonitoring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spine Surgery With Neuromonitoring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A patient who need the spine surgery

A patient who go the propofol based total intravenous anesthesia due to intraoperative neuromonitorung for spine surgery

A patient who need the cerebral artery aneurysm clipping surgery

Intervention Type PROCEDURE

A patient who go the propofol based total intravenous anesthesia due to intraoperative neuromonitorung for unruptured cerebral artery aneurysm clipping surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A patient who need the cerebral artery aneurysm clipping surgery

A patient who go the propofol based total intravenous anesthesia due to intraoperative neuromonitorung for unruptured cerebral artery aneurysm clipping surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients, ASA Classification I-Ⅲ between 20 and 70 years, scheduled the neuromonitoring for spine surgery in department of neurosurgery

Exclusion Criteria

Taking thiazide/ACEi /ARB for hypertension

* Receiving insulin treatment due to diabetes mellitus
* Diagnosed with kidney disease or GFR \< 60
* Diagnosed with liver disease or AST/ALT \> 100
* Receiving furosemide or mannitol before surgery
* DI was diagnosed before surgery or having polyuria
* Taking lithium or antibiotics that are known to cause DI
* Do not understand Korean language
* Vulnerable subjects who are unable to obtain consent forms

Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No